DIRS.INFO The most relevant business & tech news

☆ A wargame simulated a 2nd Trump presidency. It concluded NATO would collapse.
▼ + stars: | 2024-05-12 | by ( Michael Peck | ) www.businessinsider.com time to read: +9 min

If Donald Trump wins a second term in the White House in November, NATO may fall apart, a recent wargame found. "What Donald Trump can do is just really hollow out what NATO does," Grimble told Business Insider. The UK has traditionally backed a transatlantic, America-Europe alliance rather than a purely European defense bloc. Yet in the game, it could neither persuade Trump to ease his demands, nor the European NATO members to spend more on defense. "Many NATO members — except for France mainly — thought post-Trump it could be salvageable," Grimble said.

Persons: Donald Trump, Trump, Finley Grimble, Grimble, John Bolton, —, SACEUR, Jens Stoltenberg, NICHOLAS KAMM, hadn't, I'm, Florian Gaertner, Russia doesn't, God's, Michael Peck Organizations: Service, House, NATO, EU, US, Business, US National Security, Allied, Europe, Washington, Nato, Getty, European Union, Joint Expeditionary Force, Northern, —, European NATO, Trump, Defense, Foreign Policy, Rutgers Univ, Twitter, LinkedIn Locations: Europe, Russia, NATO, Ukraine, China, American, United States, Finland, Romania, Poland, Baltic, France, Germany, French, America, Italy, Estonia, British, Turkey, Baltic States, Ukraine stalemated, Moscow, Russian, Kyiv . Europe, Beijing, Taiwan, Japan, Australia, South Korea, Iran, Saudi Arabia, European, Forbes

☆ Solving the looming retirement crisis means thinking differently about aging, economist says
▼ + stars: | 2024-03-16 | by ( George Glover | ) www.businessinsider.com time to read: +7 min

It's time to start thinking differently about aging, according to a new book. "We've never invested enough in old age, because we never thought we'd get there," he said. "We've never invested enough in old age, because we thought we'd never get there, and now we will." He calls for a transition to an "evergreen economy," based on channeling the world's aging population to address inequality and boost growth. AdvertisementThe looming retirement crisis underlines the need for a rethink on aging, Scott told BI.

Persons: Andrew J, Scott, We've, we'd, —, There's, Florian Gaertner, we're, that's, they've, David Bowie, Magdalena Wosinska, he's, Bryan Johnson, who's, I've, I'm Organizations: Service, Health, Institute for Fiscal, London Business School, Harvard, Bank of England, Institute for International Political, Economic, Getty, Social Security, Washington Post Locations: Oxford, Japan

☆ Big Tech's AI spending plans mean big business for 3 portfolio stocks, including Nvidia
▼ + stars: | 2024-02-02 | by ( Kevin Stankiewicz | In Kevinstankiewicz | ) www.cnbc.com time to read: +9 min

Some of Amazon's spending is likely to go toward its custom AI chips, known as Trainium and Inferentia. But the Seattle-based tech giant also buys Nvidia chips. On Thursday's post-earnings call, CEO Andy Jassy said AWS offers the "most expansive collection of compute instances with Nvidia chips." Alphabet's spending on AI chips has typically been split between its custom chips designed in partnership with Broadcom, known as Tensor Processing Units (TPUs), and Nvidia's offerings. Including networking products that stitch together parts of the data center, about 15% of Broadcom's semiconductor revenue was tied to generative AI spending in fiscal 2023.

Persons: Eaton, Brian Olsavsky, FactSet, Amazon's capex, Andy Jassy, Meta's capex, Susan Li, Li, Mark Zuckerberg, Zuckerberg, Meta, it's, —, Amy Hood, It's, chatbot ChatGPT, AMD's, Ruth Porat, Porat, Jim Cramer's, Jim Cramer, Jim, Florian Gaertner Organizations: Big Tech, Nvidia, Broadcom, Eaton, Microsoft, Meta, Google, Web Services, Facebook, Devices, OpenAI, supercomputing, TPUs, CNBC, YouTube, Photothek, Getty Locations: Eaton, Seattle

☆ Healthcare companies are promising to help patients quit Wegovy. There's just one problem with that.
▼ + stars: | 2023-12-19 | by ( ) www.businessinsider.com time to read: +11 min

Inkinen said Virta can help patients quit GLP-1 drugs and keep weight off by adjusting the foods they eat to help them feel full, similar to how the drugs reduce feelings of hunger. About 82% of patients taking Wegovy experience gastrointestinal issues like nausea and diarrhea. WeightWatchers didn't provide Business Insider with published data to support its claims that it can help people keep weight off after quitting weight-loss drugs. AdvertisementHe also advises the weight-loss startup Calibrate, which tapers some patients off GLP-1 drugs after they reach a certain body-mass index. GLP-1 drugs also slash the risk of heart attacks, strokes, and cardiac-related death.

Persons: —, Michael Albert, aren't, Sami Inkinen, Inkinen, Virta, Michael Siluk, Noom's, Linda Anegawa, Carolina Rudah, tirzepatide, Mounjaro, Zepbound —, Eli Lilly, Ozempic, Wegovy, Randy Seeley, Seeley, Robyn Phelps, it's, Robert Kushner, Kushner, Florian Gaertner, It's, Albert, Lisa, she's, I'm Organizations: Service, Business, FDA, Virta, Getty, Nordisk, Michigan Nutrition Obesity Research, University of Michigan, Novo Nordisk, Northwestern University Locations: Denver, Michigan

☆ Once loyal Calibrate patients say they regained weight after the startup struggled to get them weight-loss meds on time
▼ + stars: | 2023-11-02 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +14 min

Christina started taking Wegovy in September 2021 after getting a prescription through Calibrate, a startup that promises science-backed help with weight loss. She never received medication through Calibrate again, and she's since gained back all the weight she lost. Calibrate says its goal for Masters patients is to get them off weight-loss medications and help them maintain the weight loss they achieved. A former employee on Calibrate's clinical team said the startup allocated fewer doctors to second-year patients because those patients historically required less help from Calibrate. At least four second-year patients Insider spoke with said they sought refunds from Calibrate after they didn't receive the services they paid for.

Persons: Christina, She'd, I'm, Florian Gaertner, they've, They've, Isabelle Kenyon, Kenyon, Fortune, Jenny Craig, Ozempic, it's, Katie, Calibrate's, didn't, It's, James, they'd, Arantza Pena Popo, Disha, aren't, hasn't, Michael Siluk, Beth Organizations: Getty, Calibrate's, Better, LinkedIn Locations: York, Chicago

☆ Germany needs structural change to prevent a shift to the right, Commerzbank CEO says
▼ + stars: | 2023-09-22 | by ( Hannah Ward-Glenton | ) www.cnbc.com time to read: +2 min

The sun sets behind the lignite-fired power plant of Boxberg on August 18, 2023 in Neuliebel, Germany. Florian Gaertner | Photothek | Getty ImagesGermany needs to implement structural changes if it wants to prevent a political shift to the right, Commerzbank CEO Manfred Knof told CNBC at the Handelsblatt Banking Summit 2023. Knof also said Germany's small-to-medium-sized companies, known as the Mittelstand, were reluctant to invest in their own country because of the structural issues in Europe's largest economy. "We need more activities and ... [a] better framework for the German SMEs to invest in this country," he added. "A lot of family-owned companies ... have very operational plans to relocate," Russwurm said, adding that the current business conditions in Germany had created a "cocktail" of obstacles for companies.

Persons: Florian Gaertner, Manfred Knof, Knof, Siegfried Russwurm, CNBC's Annette Weisbach, Russwurm Organizations: Photothek, Getty, CNBC, Handelsblatt, Federal Ministry for Economic Affairs, Germany, German Industry Federation Locations: Boxberg, Neuliebel, Germany, Bavaria, Europe's

☆ A $7 billion startup wanted to build patient-friendly healthcare. Its bet on buzzy weight-loss drugs is testing that vision.
▼ + stars: | 2023-06-29 | by ( Blake Dodge | Rebecca Torrence | ) www.businessinsider.com time to read: +12 min

Patient complaints go beyond the Wegovy shortageKaitlyn's complaints echo an array of issues faced by other Ro patients seeking weight-loss drugs. The patients Insider interviewed asked to be identified by their first names to protect their privacy. In this chat log, a Ro weight-loss patient sends messages to the startup asking to cancel the program. Reitano told Insider that around 90% of Ro patients got a response within 24 hours. "Until these DTC companies generally start getting into the muck of healthcare, they're not going to have a material impact," Parker told Insider.

Persons: Ro, Zachariah Reitano, Reitano, Li Ran, Robyn Phelps, Kaitlyn, She'd, didn't, she's, couldn't, Max Kerwick, drugstores, Max, Ro's, aren't, hasn't, Florian Gaertner, it's, TJ Parker, they're, Parker Organizations: New York, Getty, Better Business Bureau, Nordisk, Better Business, CareMetx, Ro, TechCrunch Locations: Xinhua, New York, New York City

☆ Inside your company's struggle over whether to pay for hot, new weight-loss drugs
▼ + stars: | 2023-06-20 | by ( ) www.businessinsider.com time to read: +10 min

Americans are clamoring for new weight-loss drugs, but companies aren't rushing to pay for them. At most, half of US employers help pay for weight-loss drugs for their workers, according to several estimates. "The drug companies, providers, and patient groups are insisting that weight loss will improve health and therefore offset these massive costs. Known as GLP-1 agonists, the drugs — Wegovy and Ozempic from Novo Nordisk and Eli Lilly's Mounjaro — mimic a gut hormone known as glucagon-like peptide 1, helping to suppress people's appetites and slow their digestion. Brent Eberle, the chief pharmacy officer at Navitus, said very few of the employers that worked with his pharmacy-benefit manager paid for weight-loss drugs.

Persons: that's, They're, AJ Loiacono, Li Ran, James Gelfand, Eli Lilly's, Ozempic, drugmakers, Brent Eberle, Navitus, Eberle, it's, Pat Gleason, Gleason, Wegovy, Eli Lilly, Lilly, Florian Gaertner, Loiacono Organizations: Morning, Novo Nordisk, Getty, Workers, Drugmakers, Therapeutics, Blue, Mayo Clinic, and Drug Administration, Capital Locations: Novo, Xinhua

Search resuls for: "Florian Gaertner"

8 mentions found